Cholangiocarcinoma cell line TK may be useful for the pharmacokinetic study of the chemotherapeutic agent gemcitabine
Open Access
- 30 May 2014
- journal article
- Published by Spandidos Publications in Oncology Reports
- Vol. 32 (2) , 829-834
Abstract
Cholangiocarcinoma is a disease with a poor prognosis. A human cholangiocarcinoma cell line, TK, was previously established to enable further understanding of the disease. We conducted this investigation to determine whether or not the TK line is useful for pharmacokinetic study of the chemotherapeutic agent gemcitabine (GEM). Along with the BXPC3 human pancreatic adenocarcinoma cell line, the sensitivity to and effects on the TK cell line of GEM were compared. The influence of deoxycytidine kinase (dCK) transduction was also comparatively investigated. The effects of GEM in terms of drug sensitivity of the TK cell line, cell cycle and levels of transcripts of key enzymes were comparable to the BXPC3 cell line. Responses to the drug were similar in both cell lines. In contrast to pancreatic carcinoma, cell lines for research on cholangiocarcinoma have been limited. This study suggests the application of the TK cell line to the pharmacokinetic study of the chemosensitization of therapeutic drugs, such as GEM.Keywords
This publication has 19 references indexed in Scilit:
- Morphological study of the TK cholangiocarcinoma cell line with three-dimensional cell cultureMolecular Medicine Reports, 2014
- Cholangiocarcinoma among offset colour proof-printing workers exposed to 1,2-dichloropropane and/or dichloromethaneOccupational and Environmental Medicine, 2013
- Targeted therapy for biliary tract cancersJournal of Hepato-Biliary-Pancreatic Sciences, 2012
- Human equilibrative nucleoside transporter 1 (hENT1) expression is a potential predictive tool for response to gemcitabine in patients with advanced cholangiocarcinomaEuropean Journal of Cancer, 2011
- Gene expression analysis for predicting gemcitabine resistance in human cholangiocarcinomaJournal of Hepato-Biliary-Pancreatic Sciences, 2011
- Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomasBMC Cancer, 2010
- MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3 #Hepatology, 2009
- mir-29 regulates Mcl-1 protein expression and apoptosisOncogene, 2007
- Involvement of Human Micro-RNA in Growth and Response to Chemotherapy in Human Cholangiocarcinoma Cell LinesGastroenterology, 2006
- HIGH LEVEL OF CA19-9, CA50, AND CEA-PRODUCIBLE HUMAN CHOLANGIOCARCINOMA CELL LINE CHANGES IN THE SECRETION RATIOS IN VITRO OR IN VIVOIn Vitro Cellular & Developmental Biology - Animal, 2000